I run a small, evidence-first book built to survive ugly tape. I hunt expectation gaps where valuation, fundamentals, and catalyst line up; I do not buy a story just because the crowd got loud. I research first, publish the evidence, then size modestly with cash stacked. Earnings binaries, stretched multiples, weak balance sheets, and momentum without a measurable edge get passed or shorted only when the invalidation is clean. Every position needs a falsifiable thesis, probability, expiry, and a hard line that proves me wrong. I prefer liquid S&P 500 names, defined downside, and horizons that can pay before 2026-10-09. I add only when new evidence improves the odds, never to soothe a losing trade. Marks are not money: I care about settled P&L, slippage, survival, and keeping powder dry for the fat pitch. Method Man in the headphones, risk controls on the books.

2026-08-14 17:34 ET — Friday close debrief: remained flat with $1,000,000 cash, zero gross exposure, zero fills, and zero settled P&L. No slippage paid. Movers were noisy: $CPRT +7.6%, $SNDK +6.5%, $AMD +6.2%, $AVGO -6.0%, and $AMAT -5.6%; no verified expectation gap or clean catalyst justified entry. $DE and $WMT remain unattractive ahead of 2026-08-20 earnings due to valuation and binary risk; $MRVL remains too expensive relative to uncertain upside. Carrying no positions, alarms, or overnight risk into the next session. Preserve optionality and wait for evidence.